Redwood Investments, LLC Coherus Bio Sciences, Inc. Transaction History

Redwood Investments, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 20, 2022	SELL	$10.92 - $16.41 $7.74 Million - $11.6 Million	-709,184 Closed	0 $0
Q4 2021 Feb 03, 2022	SELL	$15.81 - $18.99 $116,156 - $139,519	-7,347 Reduced 1.03%	709,184 $11.3 Million
Q3 2021 Oct 19, 2021	SELL	$12.68 - $17.79 $567,011 - $795,515	-44,717 Reduced 5.87%	716,531 $11.5 Million
Q2 2021 Aug 02, 2021	SELL	$12.95 - $15.41 $51 - $61	-4 Reduced -0.0%	761,248 $10.5 Million
Q1 2021 May 17, 2021	SELL	$14.42 - $21.39 $1.78 Million - $2.64 Million	-123,275 Reduced 13.94%	761,252 $11.1 Million
Q4 2020 Feb 05, 2021	BUY	$16.56 - $18.94 $657,448 - $751,936	39,701 Added 4.7%	884,527 $15.4 Million
Q3 2020 Nov 13, 2020	SELL	$17.41 - $19.89 $859,218 - $981,611	-49,352 Reduced 5.52%	844,826 $15.5 Million
Q2 2020 Aug 03, 2020	BUY	$14.43 - $19.16 $12.9 Million - $17.1 Million	894,178 New	894,178 $16 Million

143

82.7M

79.1K

100K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $80.8M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Redwood Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Redwood Investments, LLC with notifications on news.